The side effects of serrapeptase

Updated April 17, 2017

Serrapeptase is a proteolytic enzyme that is effective in pain treatment. It also useful in a number of other medical and dental problems. The drug reduces swelling and cuts down on the formation of blood clots and plaque blockage.


As of May, 2009, serrapeptase has exhibited no serious side effects in clinical trials or in public use. A few patients have reported a skin rash, mild headache, stomach discomfort and other minor aches and pains. However, the symptoms were mild in nature and disappeared after a few days.


Serrapeptase was discovered inside the intestines of the silk worm; however, the depletion of the worm's population and increased demand for the drug has led to an insufficient harvest quantity. Now serratia peptidase, which comes from the fermentation of enterobacteria known as Serratia E15, is used instead.


Serrapeptase can digest arterial plaque, blood clots, cysts and dead tissue within the body. This can lead to the prevention of certain heart conditions as well as stroke.


A natural anti-inflammatory, serrapeptase may be more effective in treating pain than NSAIDs according to Physician Formulas. It is used to treat asthma, carpal tunnel syndrome, cluster headache, Chohn's disease, colitis, cystitis, emphysema, enlarged prostate and many other conditions.


Although research is ongoing, evidence suggests serrapeptase could eliminate a serious medical condition known as hardening of the arteries. Additionally, its ability to reduce swelling could indicate an important role in postoperative medical and dental treatment.

Cite this Article A tool to create a citation to reference this article Cite this Article

About the Author

A business and education specialist for 30 years, Chantel Alise also owned a management and marketing training company. She has written newsletters and training manuals as well as business articles for Enid News and Eagle's Business Journal. She is principle writer for Beauty Biz. Alsie attended Thomas Nelson Community College (Virginia) and Phillips University (Oklahoma).